Teriflunomide and Time to Clinical Multiple Sclerosis in Radiologically Isolated Syndrome

🔗 Access full article via JAMA Neurology

This randomized clinical trial investigates the efficacy of the disease-modifying treatment, teriflunomide, in extending the time to a first clinical event in patients with preclinical multiple sclerosis.